Long-term follow-up in patients treated by stent implantation for post-ablation pulmonary vein stenosis

Iversen, Elisabeth; Packer, Erik; Sandberg, S.; Bleie, Øyvind; Hoff, Per Ivar; Schuster, Peter

doi:10.1007/s10840-018-0370-y

Cited by 10 publications

(8 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 7 studies reported on medical therapy after PVS angioplasty. 2 , 3 , 7 , 8 , 9 , 12 , 16 , 17 …”

Section: Discussionmentioning

confidence: 99%

“…Success rates after PV angioplasty range from only 27% to 100%. 2 , 3 , 7 , 8 , 9 , 12 , 16 , 17 Neumann et al reported on a patient cohort that was treated with postinterventional DAPT. 7 , 9 Restenosis was 73% in patients undergoing PTA alone and improved significantly after the performance of PV stenting.…”

Section: Discussionmentioning

confidence: 99%

“… 8 Another study using triple antithrombotic therapy found restenosis in only 11% of patients after concomitant angioplasty and stenting. 16 …”

Section: Discussionmentioning

confidence: 99%

“…8 Another study using triple antithrombotic therapy found restenosis in only 11% of patients after concomitant angioplasty and stenting. 16 The impact of postprocedural medication in this context is poorly understood. The main factor with regard to restenosis-free survival seems to be the type of treatment strategy chosen.…”

Section: Impact Of Postprocedural Medical Therapy On Restenosis Devel...mentioning

confidence: 99%

See 3 more Smart Citations

Antithrombotic therapy after angioplasty of pulmonary vein stenosis due to atrial fibrillation ablation: A two‐center experience and review of the literature

Fink

Vogler

Proietti

et al. 2022

Journal of Arrhythmia

View full text Add to dashboard Cite

Background Pulmonary vein stenosis (PVS) is a severe complication of atrial fibrillation (AF) ablation resulting in narrowing of affected pulmonary veins (PVs). Interventional treatment consists of angioplasty with or without PV stenting. The optimal postprocedural antithrombotic therapy is not known. Study aims To investigate the impact of antithrombotic medical therapy on recurrence of PVS after PV angioplasty. Methods A retrospective study of patients undergoing PV angioplasty with or without stent implantation in two German centers was performed. Postinterventional antithrombotic therapy consisted of either dual antiplatelet therapy (DAPT) or a combination of oral anticoagulation with single or dual antiplatelet therapy for 3–12 months after intervention. Angiographic follow‐up was recommended 3, 6, and 12 months after intervention and in case of symptom recurrence. Results Thirty patients underwent treatment of 42 PVS. After intervention, twenty‐eight patients received triple therapy and 14 patients received dual therapy/DAPT; restenosis occurred in 5/22 (22.7%) patients with triple therapy and 8/14 (57.1%) patients with dual therapy/DAPT PV (p = .001). Estimated freedom from PV restenosis after 500 days was 18.8 ± 15.8% (dual therapy/DAPT) and 76.2 ± 10.5% (triple therapy) (p = .003). Univariate regression analysis revealed postprocedural medication as a significant risk factor for restenosis (p = .019). No bleeding events occurred regardless of applied antithrombotic therapy. Conclusion Triple antithrombotic therapy after PV angioplasty is associated with less frequent restenosis as compared to dual antiplatelet therapy or a combination of anticoagulation and single antiplatelet therapy. No severe bleeding events occurred in patients on triple therapy. These findings need to be confirmed in larger patient cohorts.

show abstract

“…A total of 7 studies reported on medical therapy after PVS angioplasty. 2 , 3 , 7 , 8 , 9 , 12 , 16 , 17 …”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“… 8 Another study using triple antithrombotic therapy found restenosis in only 11% of patients after concomitant angioplasty and stenting. 16 …”

Section: Discussionmentioning

confidence: 99%

Section: Impact Of Postprocedural Medical Therapy On Restenosis Devel...mentioning

confidence: 99%

See 2 more Smart Citations

Antithrombotic therapy after angioplasty of pulmonary vein stenosis due to atrial fibrillation ablation: A two‐center experience and review of the literature

Fink

Vogler

Proietti

et al. 2022

Journal of Arrhythmia

View full text Add to dashboard Cite

show abstract

“…Nonetheless, close monitoring seems essential, because the consequences of exercise-induced pulmonary hypertension on the pulmonary vasculature remain largely unknown. On the other hand, symptomatic stenosis often requires percutaneous (eg, balloon dilatation and stent placement) or surgical intervention, and stent implantation appears to be the treatment of choice, as a lower restenosis rate compared to balloon angioplasty 11 and good long-term outcomes 12 have been reported. Surgical intervention is considered when the percutaneous approach has failed, or irreversible pulmonary vascular remodeling has developed.…”

Section: Discussionmentioning

confidence: 99%

A case of pediatric atrial fibrillation ablation resulting in unilateral pulmonary vein occlusion during long-term follow-up

Fukudome

Suzuki

Shimeno

et al. 2022

HeartRhythm Case Reports

View full text Add to dashboard Cite

A case of pediatric atrial fibrillation ablation resulting in unilateral pulmonary vein occlusion during longterm follow-up, HeartRhythm Case Reports (2022), doi: https://doi.org/10.1016/j.hrcr.2021.12.017. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Comprehensive review of pulmonary vein stenosis post-atrial fibrillation ablation: diagnosis, management, and prognosis

Tokuda,

Ogawa,

Tokutake

et al. 2024

Cardiovasc Interv and Ther

View full text Add to dashboard Cite

Long-term follow-up in patients treated by stent implantation for post-ablation pulmonary vein stenosis

Abstract: Symptomatic PVS after AF ablation can be successfully treated by stent implantation with durable results and good clinical outcome. AF ablation is still a feasible option after stent deployment.

Cited by 10 publications

References 14 publications

Antithrombotic therapy after angioplasty of pulmonary vein stenosis due to atrial fibrillation ablation: A two‐center experience and review of the literature

Antithrombotic therapy after angioplasty of pulmonary vein stenosis due to atrial fibrillation ablation: A two‐center experience and review of the literature

A case of pediatric atrial fibrillation ablation resulting in unilateral pulmonary vein occlusion during long-term follow-up

Comprehensive review of pulmonary vein stenosis post-atrial fibrillation ablation: diagnosis, management, and prognosis

Contact Info

Product

Resources

About